These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 426290)

  • 1. Measurement of 3,4-dihydroxyphenylacetic acid and 3-methoxytyramine specific activity rat striatum.
    Di Giulio AM; Groppetti A; Algeri S; Ponzio F; Cattabeni F; Galli CL
    Anal Biochem; 1979 Jan; 92(1):82-90. PubMed ID: 426290
    [No Abstract]   [Full Text] [Related]  

  • 2. 3-Methoxytyramine and different neuroleptics: dissociation from HVA and DOPAC.
    Groppetti A; Parenti M; Galli CL; Bugatti A; Cattabeni F; Di Giulio AM; Racagni G
    Life Sci; 1978 Oct; 23(17-18):1763-8. PubMed ID: 31531
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid concurrent automated fluorimetric assay of noradrenaline, dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid and 3-methoxytyramine in milligram amounts of nervous tissue after isolation on Sephadex G10.
    Westerink BH; Korf J
    J Neurochem; 1977 Oct; 29(4):697-706. PubMed ID: 591945
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid post mortem changes in 3,4-dihydroxyphenylacetic acid (DOPAC), a dopamine metabolite, in rat striatum.
    Moleman P; Bruinvels J; Westerink BH
    J Neurochem; 1977 Jul; 29(1):175-7. PubMed ID: 886321
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in specific activity of dopamine metabolites as evidence of a multiple compartmentation of dopamine in striatal neurons.
    Groppetti A; Algeri S; Cattabeni F; Di Giulio AM; Galli CL; Ponzio F; Spano PF
    J Neurochem; 1977 Jan; 28(1):193-7. PubMed ID: 833592
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of administration of meta-tyramine and para-tyramine on dopamine and its metabolites in the rat striatum.
    McQuade PS; Wood PL
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):705-9. PubMed ID: 6531442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute choline administration in rat and mouse: no effect on dopamine metabolism in brain.
    Flentge F; Postema F; Medema HM; Van den Berg CJ
    Life Sci; 1981 Jul; 29(4):331-5. PubMed ID: 7278490
    [No Abstract]   [Full Text] [Related]  

  • 8. Concentration of striatal tyramine and dopamine metabolism in diabetic rats and effect of insulin administration.
    Kwok RP; Juorio AV
    Neuroendocrinology; 1986; 43(5):590-6. PubMed ID: 3528901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of LSD and 2-bromo LSD on striatal DOPAC levels.
    Persson SA
    Life Sci; 1977 Apr; 20(7):1199-205. PubMed ID: 15175
    [No Abstract]   [Full Text] [Related]  

  • 10. Turnover of free and conjugated (sulphonyloxy) dihydroxyphenylacetic acid and homovanillic acid in rat striatum.
    Dedek J; Baumes R; Tien-Duc N; Gomeni R; Korf J
    J Neurochem; 1979 Sep; 33(3):687-95. PubMed ID: 479883
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of dopaminergic antagonists on striatal DOPAC concentrations and alpha-methyl-p-tyrosine-induced decline of dopamine following intrastriatal injections of kainic acid.
    Wuerthele SM; Moore KE
    J Pharm Pharmacol; 1979 Mar; 31(3):180-2. PubMed ID: 34696
    [No Abstract]   [Full Text] [Related]  

  • 12. A simple in vitro technique to measure the release of endogenous dopamine and dihydroxyphenylacetic acid from striatal tissue using high performance liquid chromatography with electrochemical detection.
    Becker JB; Castañeda E; Robinson TE; Beer ME
    J Neurosci Methods; 1984 May; 11(1):19-28. PubMed ID: 6471905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y; Komori T; Okuda S; Segawa T
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postnatal development of dopamine deamination in the striatum of the rat.
    Davis AJ; Holzbauer M; Sharman DF
    Br J Pharmacol; 1975 Dec; 55(4):558-60. PubMed ID: 1212563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of reserpine and antidepressants on dopamine and DOPAC (3,4-dihydroxyphenylacetic acid) concentrations in the striatum, olfactory tubercle and median eminence of rats.
    Fekete MI; Szentendrei T; Herman JP; Kanyicska B
    Eur J Pharmacol; 1980 Jun; 64(4):231-8. PubMed ID: 7389821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HA-966 effects on striatal dopamine metabolism: implications for dopamine compartmentalization.
    Broxterman HJ; van Valkenburg CF; Noach EL
    J Pharm Pharmacol; 1980 Jan; 32(1):67-9. PubMed ID: 6102135
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in striatal dopamine metabolism during precipitated morphine withdrawal.
    Gramsch C; Bläsig J; Herz A
    Eur J Pharmacol; 1977 Aug; 44(3):231-40. PubMed ID: 560969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of morphine to increase striatal 3,4-dihydroxyphenylacetic acid in fasted rats.
    De Montis GM; Olianas MC; Di Lorenzo C; Tagliamonte A
    Eur J Pharmacol; 1978 Jan; 47(1):121-3. PubMed ID: 618726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to stress of mesocortico-frontal dopaminergic neurones in rats after long-term isolation.
    Blanc G; Hervé D; Simon H; Lisoprawski A; Glowinski J; Tassin JP
    Nature; 1980 Mar; 284(5753):265-7. PubMed ID: 7189015
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurochemical investigations of the interaction of N,N-dimethyltryptamine with dopaminergic system in rat brain.
    Waldmeier PC; Maître L
    Psychopharmacology (Berl); 1977 Apr; 52(2):137-44. PubMed ID: 407597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.